GUELPH, ON, July 13 /CNW/ - BIOREM Inc. ("Biorem" or "the Company") (TSX-V: BRM), a leading clean technology company that designs and supplies high-efficiency biological-based air emissions control systems, announced today the receipt of three orders for its systems, totalling $1.3 million.
The first order is for the Company's two-stage skid-mounted SK series product, which will be used to treat hydrogen sulphide emissions from a wastewater treatment plant located in the South East region of the United States. The second order is for a modular Biocube system to treat hydrogen sulphide and odorous air collected from the wet well of a pumping station in the western coastal region of the United States. The third order was received from the greater Toronto area and is for a large biofilter system utilizing Biorem's Biosorbens(R) media to treat odors from a collections system.
"We continue to maintain a solid pace in winning orders for our air emissions control systems, typically beating out our competition on both the superior economics and performance of our industry leading systems," said Peter Bruijns, President and CEO.
About BIOREM Inc.
Biorem is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency biological-based air emissions control systems. These systems are used to eliminate odors, volatile organic compounds (VOCs) and hazardous air pollutants (HAPs), and for the conditioning of biogas renewable energy. With sales and manufacturing offices across the continent, a dedicated research facility, a worldwide sales representative network and more than 600 installed systems worldwide, Biorem not only offers state-of-the-art technology-based products but also peace of mind for municipalities, industrial companies and their surrounding communities. Additional information on Biorem is available on our website at www.biorem.biz.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release contains forward-looking statements based on current expectations. These forward-looking statements contain various risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Risks and uncertainties about the Company's business are more fully discussed in the disclosure materials, financial statements and MD&A filed with the securities regulatory authorities in Canada on www.sedar.com
"Order Bookings" and "Order Backlog" do not have any standardized meaning prescribed by Canadian generally accepted accounting principles ("GAAP") and may not be comparable to measures presented by other companies.
Order Bookings and Order Backlog are non-GAAP measures that the Company uses to evaluate its sales performance. Order Bookings are those binding contracts that the Company enters into with a third party for the delivery of our products or services. As Order Bookings are received, the contract value (before any associated sales taxes) is included in the Order Backlog. The Order Backlog is reduced by the revenue that is recognized on each project.
SOURCE BIOREM Inc.
For further information: For further information: Ed Corbett, Chief Financial Officer, BIOREM Technologies Inc., firstname.lastname@example.org, Tel: (519) 767-9100 x275; James Smith, Investor Relations, The Equicom Group Inc., email@example.com, Tel: (416) 815-0700 x229